Abstract: A system and method for L0 regularization-based compressed sensing (CS) may use a quantum-classical hybrid system consisting of coherent Ising machines (CIM) and classical digital processors CDP). The CIM and CDP each performs alternating minimization for L0 regularization-based compressed sensing (CS). A truncated Wigner stochastic differential equation (W-SDE) is obtained from the master equation for the density operator of the network of degenerate optical parametric oscillators.

Abstract: There is provided a method for producing an oxide catalyst, the method including a step (a) of obtaining an aqueous mixed liquid A containing Mo, V and Sb, a step (b) of mixing a Nb raw material, water and an organic acid to obtain a Nb aqueous solution, a step (c) of mixing the Nb aqueous solution and a silica raw material to obtain an aqueous mixed liquid B, a step (d) of mixing the aqueous mixed liquid A and the aqueous mixed liquid B to obtain an aqueous mixed liquid (C), a step (e) of drying the aqueous mixed liquid C to obtain a dried powder D, and a step (f) of calcining the dried powder D to obtain the oxide catalyst.

Abstract: An embodiment of the present invention stably eliminates high-frequency electromagnetic noise in a servo motor. A gear structure (10) includes: a first metal gear (1); a second metal gear (2); a first metal member (second housing 4b, motor bearing section 4c) electrically continuous with the first metal gear (1); a second metal member (shaft part 2a) electrically continuous with the second metal gear (2); and an electrical connector (conductive gasket 9) electrically connecting the first metal member and the second metal member to each other.

Abstract: A measuring apparatus includes a memory configured to store a program, and a processor configured to execute the program and perform a process including acquiring a first measured value from a first sensor that measures a weight of a subject, judging whether the first measured value satisfies a condition in which a change in the first measured value within a predetermined time is a threshold value or less, acquiring a second measured value from a second sensor that is other than the first sensor and detects biometric information of the subject other than the weight, in a case in which the judging judges that the first measured value satisfies the condition, and recording the first measured value satisfying the condition and the second measured value in correspondence with each other.

Abstract: There is provided a method for producing an oxide catalyst to be used for production of an unsaturated nitrile, the method including a step (a) of preparing an aqueous mixed liquid (A) containing Mo, V and Sb, a step (b) of mixing the aqueous mixed liquid (A), a carrier component and a Nb raw material at 20° C. or more and 80° C. or less to obtain an aqueous mixed liquid (B), a step (c) of drying the aqueous mixed liquid (B) to obtain a dried powder, and a step (d) of calcining the dried powder to obtain an oxide catalyst, wherein the aqueous mixed liquid (B) has a solid metal component concentration of 2.0 to 8.0% by mass.

Abstract: There is provided a method for producing an oxide catalyst, the method including a step (a) of obtaining an aqueous mixed liquid A containing Mo, V and Sb, a step (b) of mixing a Nb raw material, water and an organic acid to obtain a Nb aqueous solution, a step (c) of mixing the Nb aqueous solution and a silica raw material to obtain an aqueous mixed liquid B, a step (d) of mixing the aqueous mixed liquid A and the aqueous mixed liquid B to obtain an aqueous mixed liquid (C), a step (e) of drying the aqueous mixed liquid C to obtain a dried powder D, and a step (f) of calcining the dried powder D to obtain the oxide catalyst.

Abstract: The present disclosure provides lipid-containing compositions, including targeted liposomes encapsulating drug, and pharmaceutical formulations thereof, as well as methods for the making and using the lipid-containing compositions, including the use of the targeted liposomes in the treatment of cancer and other diseases.

Abstract: The present disclosure provides lipid-containing compositions, including targeted liposomes encapsulating drug, and pharmaceutical formulations thereof, as well as methods for the making and using the lipid-containing compositions, including the use of the targeted liposomes in the treatment of cancer and other diseases.

Abstract: The present disclosure provides lipid-containing compositions, including targeted liposomes encapsulating drug, and pharmaceutical formulations thereof, as well as methods for the making and using the lipid-containing compositions, including the use of the targeted liposomes in the treatment of cancer and other diseases.

Abstract: The present disclosure provides lipid-containing compositions, including targeted liposomes encapsulating drug, and pharmaceutical formulations thereof, as well as methods for the making and using the lipid-containing compositions, including the use of the targeted liposomes in the treatment of cancer and other diseases.

Abstract: The present disclosure provides lipid-containing compositions, including targeted liposomes encapsulating drug, and pharmaceutical formulations thereof, as well as methods for the making and using the lipid-containing compositions, including the use of the targeted liposomes in the treatment of cancer and other diseases.